[The possible relationship between the antifibrillatory effect of inderal in experimental myocardial infarct and its effect on cardiac oxidation reduction processes and blood supply].
D000818:Animals; D003331:Coronary Vessels / Q000187:drug effects*; D004285:Dogs; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D009206:Myocardium / Q000378:metabolism; D010084:Oxidation-Reduction; D010101:Oxygen Consumption; D011199:Potentiometry; D011433:Propranolol / Q000627:therapeutic use*; D014693:Ventricular Fibrillation / Q000209:etiology / Q000517:prevention & control*
D011433:Propranolol
O vozmozhnoi zavisimosti antifibrilliatornogo deistvia inderala pri eksperimental'nom infarkte miokarda ot ego vliianiia na okislitel'no-vosstanovitel'nye protsessy i krovosnabzhenie serdtsa.